Merck Files Second Suit Against Teva Over Singulair

Law360, New York (May 16, 2007, 12:00 AM EDT) -- Not content to bring just one suit against Teva Pharmaceuticals USA over a generic version of asthma and allergy medication Singulair, Merck & Co. Inc. let a Barbados-based subsidiary file a second patent suit against the Israeli generics maker on Monday.

The second lawsuit, also in the U.S. District Court for the District of New Jersey, comes just over a month after Merck filed the first one. It charges Teva with the same claim of violating the Singulair patent by filing an Abbreviated New Drug Application...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.